Study summary

The purpose of this study is to evaluate the long-term safety and efficacy of ASP015K in subjects with Rheumatoid Arthritis (RA) who have completed a preceding Phase 2 ASP015K RA study.

Additional Study Details

Phase
2
Product
N/A
Product
peficitinib
Type
Interventional
Masking
None (Open Label)
Enrollment number
611
Show Additional Study Details

Study documents

Scientific Results Summary
Available Language(s): English
Plain Language Summary
Available Language(s): English

Get more information

Would you like more information about clinical trial sites that are recruiting participants for A Study to Evaluate the Long-term Safety and Efficacy of ASP015K in Subjects Previously Enrolled in a Phase 2 ASP015K Rheumatoid Arthritis Study? Contact us by filling out your information to the right and we’ll respond to you.

  • A caregiver
  • A healthcare provider
  • A parent
  • A patient
  • A patient advocate
  • Algeria
  • Argentina
  • Armenia
  • Australia
  • Austria
  • Belarus
  • Belgium
  • Bosnia And Herzegovina
  • Brazil
  • Bulgaria
  • Canada
  • Chile
  • China
  • Colombia
  • Croatia
  • Czech Republic
  • Denmark
  • Dominican Republic
  • Egypt
  • Estonia
  • Finland
  • Former Serbia and Montenegro
  • France
  • Georgia
  • Germany
  • Greece
  • Guatemala
  • Hong Kong
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Ireland
  • Israel
  • Italy
  • Japan
  • Jordan
  • Kazakhstan
  • Latvia
  • Lebanon
  • Lithuania
  • Macedonia
  • Malaysia
  • Mexico
  • Montenegro
  • Morocco
  • Netherlands
  • New Zealand
  • Norway
  • Panama
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Puerto Rico
  • Republic of Korea
  • Republic of Moldova
  • Romania
  • Russian Federation
  • Saudi Arabia
  • Serbia
  • Singapore
  • Slovakia
  • Slovenia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Taiwan, Province of China
  • Thailand
  • Turkey
  • Ukraine
  • United Kingdom
  • United States
  • Vietnam

By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

    Locations

    Contact Us
    Contact Us
    Completed
    Site HU3448
    Budapest, Hungary, 1027
    Completed
    Site CO3450
    Bucaramanga, Colombia
    Completed
    Site US291
    Wheaton, MD, United States, 20902
    Completed
    Site US219
    Palo Alto, CA, United States, 94304
    Completed
    Site US3218
    Birmingham, AL, United States, 35216
    Completed
    Site US3300
    Oklahoma City, OK, United States, 73103
    Completed
    Site US3226
    Vernon Hills, IL, United States, 60061
    Completed
    Site MX3317
    Morelia, Mexico, 58070
    Completed
    Site MX3238
    Guadalajara, Mexico, 44650
    Completed
    Site HU3398
    Bekescsaba, Hungary, 5600
    Completed
    Site CZ3449
    Zlin, Czech Republic, 760 01
    Completed
    Site HU3462
    Budapest, Hungary, 1027
    Completed
    Site PL3391
    Bialystok, Poland, 15-879
    Completed
    Site US3298
    Hickory, NC, United States, 28602
    Completed
    Site CO3451
    Cali, Colombia
    Completed
    Site US3319
    Austin, TX, United States, 78705
    Completed
    Site BG3613
    Burgas, Bulgaria, 8000
    Completed
    Site US3232
    Orlando, FL, United States, 32804
    Completed
    Site HU3302
    Budapest, Hungary, 1027
    Completed
    Site PL3600
    Warszawa, Poland, 02-118
    Completed
    Site PL2893
    Bydgoszcz, Poland, 85-168
    Completed
    Site US3306
    Knoxville, TN, United States, 37909
    Completed
    Site PL3233
    Bialystok, Polska, Poland, 15-351
    Completed
    Site US702
    Morton Grove, IL, United States, 60053
    Completed
    Site CZ3388
    Praha 2, Czech Republic, 128 50
    Completed
    Site US3227
    Palm Desert, CA, United States, 92260
    Completed
    Site PL3599
    Warszawa, Poland, 02-653
    Completed
    Site US3329
    Elizabethtown, KY, United States, 42701
    Completed
    Site BG3303
    Sofia, Bulgaria, 1612
    Completed
    Site CO2826
    Bucamaranga, Colombia
    Completed
    Site US345
    Duncansville, PA, United States, 16635
    Completed
    Site US3304
    Wyomissing, PA, United States, 19610
    Completed
    Site MX3307
    Guadalajara, Jalisco, Mexico, 44280
    Completed
    Site CZ3225
    Uherske Hradiste, Czech Republic, 68601
    Completed
    Site PL3601
    Lublin, Poland, 20-582
    Completed
    Site BE3314
    Brussels, Belgium, 1190
    Completed
    Site PL3603
    Krakow, Poland, 31-637
    Completed
    Site US3327
    Chesapeake, VA, United States, 23320
    Completed
    Site MX3310
    Mexico, Mexico, 6700
    Completed
    Site CZ3376
    Praha-Nusle, Czech Republic, 140 00
    Completed
    Site HU3447
    Debrecen, Hungary, H-4043
    Completed
    Site BE3387
    Brussels, Belgium, 1070
    Completed
    Site CO3297
    Bogota, Colombia
    Completed
    Site US3331
    Colorado Springs, CO, United States, 80920
    Completed
    Site US3320
    Clarksburg, WV, United States, 26301
    Completed
    Site US3332
    Santa Maria, CA, United States, 93454
    Completed
    Site US828
    LaJolla, CA, United States, 92093-0943
    Completed
    Site US1894
    Jacksonville, FL, United States, 32216
    Completed
    Site BG3217
    Plovdiv, Bulgaria, 4003
    Completed
    Site CO3326
    Barranquilla, Atlantico, Colombia
    Completed
    Site HU3461
    Balatonfüred, Hungary, 8230

    Frequently Asked Questions

    Are clinical trials only for people with advanced cancer?

    While some clinical trials may focus on more advanced cancers, many trials are open to patients at various stages of their cancer. Each study has rules about who can take part. For example, only patients in a certain age group or those who have a certain type of tumor may be able to join.

    Will I have to stop my current treatment to participate in a clinical trial?

    Sometimes researchers want participants to keep taking their current treatments during a clinical trial. Other times, you may need to stop your current treatments for a while. If the investigational treatment doesn't work, you can usually go back to your original treatment plan.

    Should I be worried about getting a placebo?

    In cancer clinical trials, a placebo is only used if there is no other treatment for that type of cancer. This helps compare an investigational treatment to the placebo. Placebos are rarely used in cancer trials because the best available treatment, called the “standard of care”, is usually given instead.

    Do I need a referral from my doctor to take part in a study?

    Your doctor may not know about all the opportunities for clinical trials that are available to you. Talk to your doctor or other medical provider about clinical trial information that you find. They can help you decide if a clinical trial is right for you. If you do not find any options on this website, we recommend you visit an online public registry website like clinicaltrials.gov to see a wide variety of available clinical trials.

    Explore More

    1

    What are clinical trials?

    2

    Why are Clinical Trials Important?

    3

    Why Participate in a Clinical Trial?